ArticleCrohn's & colitis 3602026

Efficacy and safety of ABBV-154 in patients with moderately to severely active Crohn's disease: a phase 2b, randomized, double-blind, placebo-controlled trial.

Walter Reinisch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.